United States
Print page content Print
Increase text size Decrease text size
Text Size

Clinical Use

Dosage and Administration

  • Always provide Client Information Sheet with prescription.
  • Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day.1
  • Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions1
  • Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter. PALLADIA may be administered with or without food. Do not split tablets. (see Prescribing Information)1

Considerations for Monitoring

Specific monitoring varies based on individual patient needs, please adjust the schedule below based on your clinical judgment:

Visit
CBC
Serum Chemistry
Urinalysis
Weight
Baseline
Week 1
 
 
Week 2
 
 
Week 3
Optional
 
 
Optional
Week 4
Every 4 Weeks

*Test hemoccult and weight only if health concerns remain.


  Dosing Chart

  Monitoring and Rechecks

IMPORTANT SAFETY INFORMATION: During clinical studies, the most common adverse events associated with PALLADIA included: diarrhea, anorexia (including decreased appetite), lethargy, neutropenia, emesis, lameness, weight loss, musculoskeletal disorder, and blood in stool/GI bleed/hemorrhagic diarrhea. PALLADIA may cause vascular dysfunction, which can lead to edema and thromboembolism, including pulmonary thromboembolism. Serious and sometime fatal GI complications, including GI perforation, have occurred rarely in dogs treated with PALLADIA. If GI ulceration is suspected stop drug administration and treat appropriately. Children should not come in contact with PALLADIA. In addition, all individuals, including children and pregnant women, should avoid direct contact with broken or partially dissolved PALLADIA tablets or biological waste from dogs treated with PALLADIA. To report a suspected adverse reaction call Zoetis at 1-888-963-8471. See full Prescribing Information

All trademarks are the property of Zoetis Inc., its affiliates and/or its licensors. Zoetis Inc. All rights reserved. August 2015. PAL-00040

REFERENCES:

1. Package Insert